Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.
Jia-Woei
JW
Hou
D000328:Adult; D050071:Bone Density Conservation Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002675:Child, Preschool; D002864:Chromogranins; D004164:Diphosphonates / Q000008:administration & dosage* / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000235:genetics; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D008297:Male; D009999:Ossification, Heterotopic / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000077268:Pamidronate; D020641:Polymorphism, Single Nucleotide; D012868:Skin Abnormalities / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D014057:Tomography, X-Ray Computed
D050071:Bone Density Conservation Agents; D002864:Chromogranins; D004164:Diphosphonates; C406732:GNAS protein, human; D019205:GTP-Binding Protein alpha Subunits, Gs; D000077268:Pamidronate